Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bayer AG (OTC Pink - Current Information:BAYRY)

138.99
Delayed Data
As of Jun 28
 +1.40 / +1.02%
Today’s Change
91.53
Today|||52-Week Range
139.04
+33.29%
Year-to-Date
Neothetics' Fat Reduction Candidate Fails in Phase II Study
Jun 28 / Zacks.com - Paid Partner Content
AVEO Reaches Enrollment Target in Pivotal Tivozanib Study
Jun 21 / Zacks.com - Paid Partner Content
Monsanto (MON) Tops Q3 Earnings, Confirms FY17 EPS View
Jun 28 / Zacks.com - Paid Partner Content
Merrimack Completes Enrollment in Phase II Study for MM-141
Jun 20 / Zacks.com - Paid Partner Content
Monsanto (MON) Beats on Q3 Fiscal 2017 Earnings & Revenues
Jun 28 / Zacks.com - Paid Partner Content
4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio
Jun 20 / Zacks.com - Paid Partner Content
Agios/Celgene's Leukemia Candidate Positive in Phase I/II
Jun 27 / Zacks.com - Paid Partner Content
Bayer (BAYRY): Strong Industry, Solid Earnings Estimate Revisions
Jun 20 / Zacks.com - Paid Partner Content
Conatus's PSC Candidate Gets Orphan Designation in the U.S.
Jun 27 / Zacks.com - Paid Partner Content
GlaxoSmithKline's Benlysta Positive in Continuation Trial
Jun 19 / Zacks.com - Paid Partner Content
Monsanto (MON) to Report Q3 Earnings: What's in the Cards?
Jun 23 / Zacks.com - Paid Partner Content
Why Monsanto (MON) Is a Must-Add Stock to Your Portfolio
Jun 16 / Zacks.com - Paid Partner Content
Kamada Withdraws Inhaled AAT Marketing Application in EU
Jun 23 / Zacks.com - Paid Partner Content
Should Value Investors Choose Bayer AG (BAYRY) Stock Now?
Jun 16 / Zacks.com - Paid Partner Content
It's official. Business isn't investing in Britain.
Jun 22 / CNNMoney.com
Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug
Jun 15 / Zacks.com - Paid Partner Content